ArticleBMC psychiatry2020

The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index.

Daniel Schöttle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.